Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.

Roos I, Sharmin S, Ozakbas S, Alroughani R, Eichau S, Grand'Maison F, Boz C, Lechner-Scott J, Buzzard K, Prat A, Khoury SJ, Grammond P, van der Walt A, Blanco Y, Foschi M, Soysal A, Barnett M, Prevost J, Terzi M, Gerlach O, Macdonell R, Sa MJ, Spitaleri D, Laureys G, van Pesch V, John N, Cartechini E, Gouider R, Maimone D, Ramo-Tello C, Hodgkinson S, Slee M, McCombe P, Garber J, Sanchez-Menoyo JL, Al-Asmi A, Kermode AG, Lapointe E, Shaygannejad V, Van Wijmeersch B, Willekens B, Castillo-Triviño T, Taylor B, Mathey G, Le Page E, De Seze J, Ruet A, Clavelou P, Berger E, Zephir H, Kwiatkowski A, Pelletier J, Moreau T, Labauge P, Ciron J, Lebrun-Frenay C, Papeix C, Defer G, Laplaud DA, Thouvenot E, Stankoff B, Maillart E, Al-Khedr A, Bourre B, Casez O, Dos Santos A, Camdessanche JP, Hankiewicz K, Wahab A, Cabre P, Heinzlef O, Pottier C, Moulin S, Magy L, Labeyrie C, Doghri I, Vukusic S, Kalincik T, MSBase and OFSEP Study Groups

Open source

DOI: 10.1007/s40263-026-01287-8
Published: 2026 Jul
Container: CNS drugs
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40263-026-01287-8,
  title = {Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.},
  author = {Roos I and Sharmin S and Ozakbas S and Alroughani R and Eichau S and Grand'Maison F and Boz C and Lechner-Scott J and Buzzard K and Prat A and Khoury SJ and Grammond P and van der Walt A and Blanco Y and Foschi M and Soysal A and Barnett M and Prevost J and Terzi M and Gerlach O and Macdonell R and Sa MJ and Spitaleri D and Laureys G and van Pesch V and John N and Cartechini E and Gouider R and Maimone D and Ramo-Tello C and Hodgkinson S and Slee M and McCombe P and Garber J and Sanchez-Menoyo JL and Al-Asmi A and Kermode AG and Lapointe E and Shaygannejad V and Van Wijmeersch B and Willekens B and Castillo-Triviño T and Taylor B and Mathey G and Le Page E and De Seze J and Ruet A and Clavelou P and Berger E and Zephir H and Kwiatkowski A and Pelletier J and Moreau T and Labauge P and Ciron J and Lebrun-Frenay C and Papeix C and Defer G and Laplaud DA and Thouvenot E and Stankoff B and Maillart E and Al-Khedr A and Bourre B and Casez O and Dos Santos A and Camdessanche JP and Hankiewicz K and Wahab A and Cabre P and Heinzlef O and Pottier C and Moulin S and Magy L and Labeyrie C and Doghri I and Vukusic S and Kalincik T and MSBase and OFSEP Study Groups},
  year = {2026},
  journal = {CNS drugs},
  doi = {10.1007/s40263-026-01287-8},
  url = {https://doi.org/10.1007/s40263-026-01287-8}
}

RIS

TY  - JOUR
TI  - Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.
AU  - Roos I
AU  - Sharmin S
AU  - Ozakbas S
AU  - Alroughani R
AU  - Eichau S
AU  - Grand'Maison F
AU  - Boz C
AU  - Lechner-Scott J
AU  - Buzzard K
AU  - Prat A
AU  - Khoury SJ
AU  - Grammond P
AU  - van der Walt A
AU  - Blanco Y
AU  - Foschi M
AU  - Soysal A
AU  - Barnett M
AU  - Prevost J
AU  - Terzi M
AU  - Gerlach O
AU  - Macdonell R
AU  - Sa MJ
AU  - Spitaleri D
AU  - Laureys G
AU  - van Pesch V
AU  - John N
AU  - Cartechini E
AU  - Gouider R
AU  - Maimone D
AU  - Ramo-Tello C
AU  - Hodgkinson S
AU  - Slee M
AU  - McCombe P
AU  - Garber J
AU  - Sanchez-Menoyo JL
AU  - Al-Asmi A
AU  - Kermode AG
AU  - Lapointe E
AU  - Shaygannejad V
AU  - Van Wijmeersch B
AU  - Willekens B
AU  - Castillo-Triviño T
AU  - Taylor B
AU  - Mathey G
AU  - Le Page E
AU  - De Seze J
AU  - Ruet A
AU  - Clavelou P
AU  - Berger E
AU  - Zephir H
AU  - Kwiatkowski A
AU  - Pelletier J
AU  - Moreau T
AU  - Labauge P
AU  - Ciron J
AU  - Lebrun-Frenay C
AU  - Papeix C
AU  - Defer G
AU  - Laplaud DA
AU  - Thouvenot E
AU  - Stankoff B
AU  - Maillart E
AU  - Al-Khedr A
AU  - Bourre B
AU  - Casez O
AU  - Dos Santos A
AU  - Camdessanche JP
AU  - Hankiewicz K
AU  - Wahab A
AU  - Cabre P
AU  - Heinzlef O
AU  - Pottier C
AU  - Moulin S
AU  - Magy L
AU  - Labeyrie C
AU  - Doghri I
AU  - Vukusic S
AU  - Kalincik T
AU  - MSBase and OFSEP Study Groups
PY  - 2026
JO  - CNS drugs
DO  - 10.1007/s40263-026-01287-8
UR  - https://doi.org/10.1007/s40263-026-01287-8
ER  -

APA

I, R., S, S., S, O., R, A., S, E., F, G., C, B., J, L., K, B., A, P., SJ, K., P, G., A, V. D. W., Y, B., M, F., A, S., M, B., J, P., M, T., O, G., R, M., MJ, S., D, S., G, L., V, V. P., N, J., E, C., R, G., D, M., C, R., S, H., M, S., P, M., J, G., JL, S., A, A., AG, K., E, L., V, S., B, V. W., B, W., T, C., B, T., G, M., E, L. P., J, D. S., A, R., P, C., E, B., H, Z., A, K., J, P., T, M., P, L., J, C., C, L., C, P., G, D., DA, L., E, T., B, S., E, M., A, A., B, B., O, C., A, D. S., JP, C., K, H., A, W., P, C., O, H., C, P., S, M., L, M., C, L., I, D., S, V., T, K., & Groups, M. A. O. S. (2026). Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.. CNS drugs. https://doi.org/10.1007/s40263-026-01287-8

Source records

pubmed · retrieved 2026-09-25T15:08:15.665Z